Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG.L Regulatory News (MIG)

  • There is currently no data for MIG

Interim Management Statement

17 Mar 2011 09:45

Matrix Income & Growth 2 VCT plc (the Company) UNAUDITED INTERIM MANAGEMENT STATEMENT For the quarter ended 31 January 2011 In accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UKListing Authority, Matrix Income & Growth 2 VCT plc presents an InterimManagement Statement for the quarter ended 31 January 2011. The statement alsoincludes relevant financial information between the end of the period and thedate of this statement.NET ASSET VALUE PER SHARE Ordinary Shares 31 January 2011 31 October 2010 Net assets attributable to ÂŁ26,038,375 ÂŁ24,491,877shareholders Shares in issue 26,048,899 26,339,245 Net asset value per 1p Share: - Including current year income 99.96p 92.99p - Excluding current year income 99.84p 93.05p

DIVIDENDS

No dividends were paid during the quarter.

Since the quarter end, the Board has today declared an interim dividend of 4p per share, made up of 0.2p from income and 3.8p from capital. The dividend will be paid on 20 April 2011 to shareholders on the register on 1 April 2011.

SHARE BUY-BACKS

During the quarter the Company bought back 290,346 Ordinary Shares of 1p each at 57p per share. No shares have been bought back since 31 January 2011. There were 26,048,899 Ordinary Shares in issue at the date of this announcement.

INVESTMENT PORTFOLIO

The VCT made three new investments in the quarter, all in December 2010.

Firstly, the Company invested ÂŁ214,998 into the AiM listed company Omega Diagnostics Group Plc, a company providing high quality in vitro diagnostics products for use in hospitals, blood banks, clinics and laboratories in over 100 countries and specialising in the areas of food intolerance, autoimmune disease and infectious disease.

Secondly, the Company invested ÂŁ374,870 to support the MBO of Faversham House Group Limited, an established media company providing magazines, exhibitions and online resources in the environment and sustainability, visual communications and building services sectors.

Finally, the Company invested ÂŁ1 million in Apricot Trading Limited, to support the MBO of Automated Systems Group plc, a printer and copier services business with a broad customer base of schools and SMEs. Apricot Trading Limited has subsequently changed its name to ASL Technology Holdings Limited.

In January 2011, the VCT realised its entire investment in Campden Media for a cash consideration of ÂŁ836,294, compared to the previous quarter's valuation of ÂŁ345,728. This represented 85.8% of the total investment cost of ÂŁ975,000. Together with interest paid over the life of the investment the total cash return was ÂŁ1,016,150, representing 104% of cost.

In February 2011, following the quarter end, Iglu.com Holidays Limited repaid all of its loan stock of ÂŁ847,675 plus a loan premium of ÂŁ150,000 totalling ÂŁ 997,675. The Company retains an equity stake of 8.1% in Iglu.com Holidays, for a net cost of ÂŁ152,326.

Please note that all the information above is unaudited.

Other than described above, there were no material events during the period and to the date of this announcement.

For further information, please contact: Robert Brittain, for Matrix Private Equity Partners LLP, Company Secretary: 020 3206 7102.

MATRIX INCOME & GROWTH 2 VCT PLC
Date   Source Headline
26th Jul 20242:00 pmRNSGENERAL MEETINGS AND MERGER RESULTS
26th Jul 20247:30 amRNSSUSPENSION OF LISTING
24th Jul 20244:15 pmRNSNet Asset Value(s)
18th Jul 20241:31 pmRNSMERGER UPDATE AND GENERAL MEETINGS
4th Jul 20247:00 amRNSTransaction in Own shares and Total Voting Rights
1st Jul 20249:40 amRNSTotal Voting Rights and Capital
18th Jun 20245:35 pmRNSPROPOSED MERGER AND OFFERS
3rd Jun 20247:00 amRNSTotal Voting Rights and Capital
22nd May 20244:26 pmRNSDividend Declaration
22nd May 20244:21 pmRNSNet Asset Value
1st May 20247:00 amRNSTotal Voting Rights and Capital
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Mar 202410:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
21st Feb 20247:00 amRNSInterim Management Statement
20th Feb 20243:00 pmRNSDividend Declaration
1st Feb 202411:42 amRNSVoting Rights and Capital
23rd Jan 202412:45 pmRNSDirector Declaration - Non-Executive Appointment
22nd Jan 20242:00 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202310:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSINTERIM RESULTS TO 30 SEPTEMBER 2023
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20231:00 pmRNSTransaction in Own Shares
13th Sep 202312:15 pmRNSResult of AGM
13th Sep 202311:46 amRNSDividend Declaration - Replacement
13th Sep 202310:00 amRNSDividend Declaration
12th Sep 202310:30 amRNSInterim Management Statement
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
19th Jul 20233:00 pmRNSTransaction in Own Shares
13th Jul 20237:00 amRNSAnnual Financial Report
3rd Jul 20237:00 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTotal Voting Rights
2nd May 202310:00 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSTotal Voting Rights
29th Mar 202310:00 amRNSTransaction in Own Shares
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
7th Mar 20237:30 amRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
22nd Feb 20233:32 pmRNSDividend Declaration
7th Feb 20235:00 pmRNSInterim Management Statement
6th Feb 20235:25 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.